- Ongoing, recruitingPhase III and phase IV (Integrated)
MEMENTO-A Phase 3b/4 Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to assess the impact on Myocardial Structure with Cardiac Magnetic Resonance Imaging (CMR)
This study is looking at a new medicine called mavacamten for adults with a heart condition called obstructive hypertrophic cardiomyopathy (HCM). It aims to see if the medicine can reduce the thickness of the heart walls and the size of the heart's upper chambers.
For: Symptomatic Obstructive Hypertrophic CardiomyopathyHungary · Finland · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
BMS CV027-031, A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
This study is looking at a new medicine called Mavacamten for adults with a heart condition called non-obstructive hypertrophic cardiomyopathy. It aims to see if the medicine can make people feel better and improve their exercise ability over 48 weeks.
For: Non-obstructive Hypertrophic CardiomyopathyCzechia · Belgium · Norway